About us

The Organisation of Pharmaceutical Producers of India (OPPI) was established 50 years ago and represents the research-based pharmaceutical companies in India. OPPI remains committed to supporting the nation’s healthcare objectives and collaborating with all stakeholders to find sustainable solutions. OPPI believes the need for innovation must be balanced with the necessity for more accessible medicines, within a robust IP environment. A holistic approach is needed to expand healthcare in India and OPPI believes the pharmaceutical industry can form part of the solution. OPPI's stringent Code of Pharmaceuticals Practices binds all our member companies.

To understand and download the Code of Conduct on Pharmaceutical practices click here.


OPPI was formed as a representative body of the manufacturers in the pharmaceutical sector. It began functioning in July 1965 and was registered under the Companies Act on December 27 of the same year. It represented a majority of companies operating in the country, along with the public sector.

Dr Jayanta Nath Banerjee takes us down memory lane. Read more.


OPPI is an organisation of research and innovation driven pharmaceutical companies committed to addressing India's healthcare needs by:

  • Facilitating greater access to quality healthcare solutions
  • Encouraging research and innovation
  • Disseminating knowledge and sharing best practices
  • Contributing meaningfully in policy dialogues

Office bearers

Annaswamy Vaidheesh
Annaswamy Vaidheesh
VP, South Asia & Managing Director, India, GlaxoSmithKline Pharmaceuticals Ltd

Vaidheesh is a successful senior business leader with over three decades of diverse experience in healthcare and FMCG domain. He has a strong track record of leadership development and building leading brands/franchises across various categories and multi-cultural locations in Asia-pacific region. In December 2016, Vaidheesh was recognised as one of the “Most Influential Leaders of Asia” by Economic Times at the Asian Business Leaders Conclave held in Malaysia. He is a Bachelor of Physics, from Madras University and has done his Master’s Degree in Marketing Management from Bombay University. He is an Honorary Fellow of The Association of Minimal Access Surgeons of India and is a certified Process Excellence Black Belt.

Kanchana Tk

Kanchana brings almost two decades of professional experience across a range of healthcare-related businesses. Most recently, she was with Bristol Myers Squibb, where she was Lead Public Affairs for Middle East, Africa and India.

Sharad Tyagi
Sharad Tyagi
Managing Director, Boehringer Ingelheim India Pvt Ltd

Sharad has almost three decades of experience that spans across pharmaceuticals, personal care, automotive, environmental engineering, textiles & chemical industries. He is a seasoned leader with extensive global business experience. He is an MBA graduate from the Indian Institute of Management (IIM A) and holds a degree in Engineering.

Mr Sanjiv Navangul
Sanjiv Navangul
Managing Director, Janssen India (Pharmaceutical companies of Johnson & Johnson Ltd)

Sanjiv has almost three decades of experience which spans across various geographies and various business functions. He is credited with spearheading several industry firsts’ initiatives and innovative Patient Support Programs. Sanjiv holds a degree in Pharmacy and an MBA. He has been part of the Executive Management Program with Harvard.

Mr Sridhar S
Sridhar S
Managing Director, Pfizer Ltd

Sridhar is a Chartered Accountant by profession with over 24 years of experience. He served as the Chief Financial Officer of Pfizer Ltd. for a period of 7 years and was appointed as the Executive Director to the Board of Directors of the company in 2013. Sridhar assumed responsibility for Anti-Infective/Cardiovascular/Ophthalmology business along with Distribution in 2015. He was appointed as the Managing Director of the Company in 2016. Sridhar has brought about significant change in business operations/ strategic initiative in the areas of business strategy, colleague engagement, business performance and processes.

Before joining Pfizer, Mr. Sridhar held the position of Finance Director of Diageo India Pvt. Ltd. He was also on the Board of Wyeth Limited.

Dr Shailesh Ayyangar
Dr Shailesh Ayyangar
Immediate Past President- OPPI
Strategic Projects Head – General Medicines & Emerging Markets, Asia, Sanofi

With his wide-ranging experience of over three decades in the industry, Dr. Ayyangar has served as the President of OPPI from 2013 till 2017. He has been instrumental in transforming Sanofi to a major diversified healthcare company serving the patients of South Asia. Prior to Sanofi, he worked with SmithKline Beecham Pharmaceuticals and GlaxoSmithKline (GSK), in India and in Great Britain. He began his career as a practicing veterinarian in the National Dairy Development Board. In November 2016, for his outstanding achievements in business, and commitment to French-Indian relations, Dr. Ayyangar was conferred with one of the highest civilian honours - officier de l’Ordre national du Merite (Officer in the National Order of Merit) - on behalf of the Honourable President of France by H.E. Alexandre Ziegler – Ambassador of France to India.

Dr. Ayyangar holds a Master’s degree in Business Administration from the Indian Institute of Management (IIM), Ahmedabad, and holds the degree of Doctor of Veterinary Medicine from Gujarat University, India. He is an alumnus of INSEAD Business School, France having been part of the 2008 batch of Advance Management Programme.

Executive Committee


Annaswamy Vaidheesh,Vice President, South Asia & Managing Director, India, GlaxoSmithKline Pharmaceuticals Ltd


Sharad Tyagi, Managing Director, Boehringer Ingelheim India Pvt Ltd

Sanjiv Navangul, Managing Director, Janssen India-Johnson & Johnson Pvt Ltd

S. Sridhar,Managing Director, Pfizer Ltd


Ranganathan Sridhar,Managing Director, Allergan India Pvt Ltd.

Yasuhiro Nakagiri,Managing Director, Astellas Pharma India Pvt. Ltd.

Gagan Singh Bedi,Managing Director, AstraZeneca Pharma India Ltd.

Manoj Saxena,Managing Director & Country Division Head – South Asia, Bayer Pharmaceuticals Pvt. Ltd.

Jitendra Tyagi,Managing Director, Bristol-Myers Squibb India Pvt Ltd.

Dr Sanjit Singh Lamba,Managing Director, Eisai Pharmaceuticals India Pvt Ltd.

Luca Visini,Managing Director, Eli Lilly and Company (India) India Pvt Ltd.

G. Sathya Narayanan, Managing Director, Galderma India Pvt Ltd.

Milind Thatte, GM Healthcare & Managing Director, Merck Ltd.

Vivek Kamath, Managing Director, MSD Pharmaceuticals Pvt. Ltd.

Dr. Ramesh Panchagnula, Managing Director, Nektar Therapeutics (India) Pvt Ltd.

Milan Paleja, Country President & Country Head Pharmaceuticals, Novartis India Ltd.

Melvin D’Souza, Managing Director, Novo Nordisk India Pvt Ltd.

Lara Bezerra, Managing Director, Roche Products (India) Pvt Ltd.

Dr Shailesh Ayyangar,Strategic Projects Head – General Medicines & Emerging Markets, Asia – Sanofi.

Dr. Georges Jabre,Chief Executive Officer, Serdia Pharmaceuticals (India) Pvt. Ltd.

Ashok Bhattacharya,Executive Director, Takeda Pharmaceuticals India Pvt. Ltd.


Rajiv Shukla
Rajiv Shukla
Director – Alliance Development

An experienced pharmaceutical domain expert with over 23 years work experience, Rajiv has been with OPPI to close to a decade and a half. As Alliance Development Director, he has been instrumental in building working relationships with several industry associations such as IPA, CII, FICCI, AMCHAM, ASSOCHAM and IDMA, in particular. Rajiv is also responsible for major OPPI Events and Awards. Prior to OPPI, Rajiv has worked with Glaxo for 10 years in several departments. Rajiv holds a Post-Graduate degree in Management from Institute of Management Technology, Ghaziabad and a Bachelor’s degree in Science from University of Allahabad. 

Dr Ajay Sharma
Dr Ajay Sharma
Director – Government Affairs

Ajay has more than 17 years of experience spanning clinical, pharmaceutical and life sciences industry across Middle East, South Asia and Africa. As Director- Government Affairs, Ajay’s role largely focuses on leading advocacy initiatives undertaken by OPPI. He also leads the Delhi office. Prior to OPPI, Ajay worked with Frost & Sullivan for almost 6 years.  He has also been associated with 3M, Home Medical Care Company (Kuwait) and Wockhardt hospital. Ajay is a medical doctor by profession and holds a MBBS degree from Wardha Medical College and a Management degree from SP Jain, Mumbai.

Bhavna Singh
Bhavna Singh
Director - Communications

Bhavna has been a Communications professional for over 17 years. She leads the Communications function and is responsible for all communication of OPPI. Working on advocacy programmes, industry representations and media relations, Bhavna’s role focuses on designing and implementing communication strategies addressed to various stakeholders. Prior to OPPI, Bhavna headed Corporate Communications at Greaves Cotton Limited, one of the oldest engineering companies in India. She has worked in diverse industries and her expertise spans across branding, internal and external communications, research and event management. Bhavna is a recipient of several awards for her work in the field of Communications and Gender Diversity. Bhavna holds a Post Graduate Diploma in Communications and a Masters Diploma in Business Administration.

Nitika Garg
Nitika Garg
Director- Research

With 15 years of experience, Nitika leads the Research function at OPPI. As a Research Director she is responsible for providing analytical support to advocacy campaigns of the OPPI. Her understanding of the regulatory and commercial ecosystem of the pharmaceutical industry assists in strengthening OPPI’s position as knowledge partner to member companies on pharma policy. Most recently, she was working with Bristol Myers Squibb (BMS) as Associate Director, Market Research. She worked with BMS for 6 years across multiple therapy areas and projects spanning Market Research to Product launch strategies, Business strategy, Access strategy as well as Commercial excellence. Prior to BMS, Nitika has worked with leading Indian pharmaceutical companies, Glenmark and Biocon, spearheading Business Development and Marketing Strategy for new product and  commercialization for them respectively. Nitika holds a Bachelor’s degree in Biotech with a MBA in International Marketing from Symbiosis Institute of International Business (SIIB).

Shreyas Kale

Shreyas has more than two and a half decades of experience in Finance and Accounting. Shreyas leads the finance and administration function in OPPI overseeing the budget management, accounting, financial planning and analysis, and is also responsible for the smooth functioning of the Secretariat. Prior to OPPI, Shreyas has spent 21 years at Pfizer Ltd and has handled areas such as Financial Planning & Analysis, Budgeting, Forecasting, Long Range Planning, P&L Management, Pricing, Accounts Receivable & Cost Audit. A Cost Accountant from the Institute of Cost & Works Accountants of India (ICWAI), Shreyas started his career with Cadbury India Limited and has worked with Boehringer Mannheim Limited and Ciba Geigy Limited.

Work Groups and Committees

Work Groups

Work Group Chair Co-Chair
Access & Affordability Vivek Kamath
Compliance and Governance Jitendra Tyagi Sridhar Ranganathan
Finance & Taxation S. Sridhar TBD
IPR & Legal Sharad Tyagi Manoj Saxena
Medical & Regulatory Sanjiv Navangul Dr Suresh Menon
Sunila Thatte


Committees Chair Co-Chair
Human Resource Management G. Sathya Narayana Ashok Bhattacharya
Technical & Supply Chain Dr Sanjit Singh Lamba Dr Ramesh Panchagnula


Past Presidents

Late Dr H.R. Nanji Pharmed 1966
Keith C. Roy Merck Sharp Dohme 1967 - 1969
Late Brig. B. S. Bhagat Rallis 1970 - 1973
S.V. Pillai Pfizer 1974 - 1975
Late Mr Sisir Mitra Cyanamid 1976 - 1978
Late Mr H.N. Dutt Gupta East India Pharmaceutical Works 1979
Late Dr S.K. Bhattacharya Sandoz 1980 - 1981
Late Mr George Daniel Hoechst 1982 - 1984
R.N. Langrana Abbott 1985
C.M. Hattangdi Parke - Davis 1986 - 1987
Dr S. Agarwala Rallis 1988 - 1990
D.K. Bose Burroughs Wellcome 1990 - 1992
H. Dhanrajgir Glaxo 1992 - 1994
Dr Anil S. Mehta Wyeth 1994 - 1996
D. Bhadury Hoechst Marion Roussel 1996 - 1998
H.R. Khusrokhan Glaxo 1998 - 2000
Late Mr P. Gupta Infar 2000 - 2001
Tapan Ray Abbott Sept. - Nov. 2001
Ranjit Shahani Novartis 2001 - 2007
Ranga Iyer Wyeth 2007 - 2009
Ranjit Shahani Novartis 2009 - 2013
Dr. Shailesh Ayyangar Sanofi 2013 - 2017